Eurepa MF (Repaglinide/ Metformin) 1/500mg – 100 tablet

USD $75.52

Each Eurepa MF contains 1 mg Repaglinide 500 mg Metformin 100 tablets. Used to treat diabetic adults who suffer from Diabetes Mellitus type 2 diabetes.

ATC Classification: A10BD14
Active Ingrediant: Repaglinide/Metformin
Generic Name: Eurepa MF
Manufacturer: Torrent
Strength: 1/500mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 100 TABLET

Important update for customers in the USA:

The World has stopped all packages mailing to the USA due to De Minimus Exemption.

  1. This situation is real and affects the world, not just India. See your local news or this Fox Business report .
  2. We got through COVID; we will get through this as well.
  3. Suggestion: order now to hold your place — shipping will be first-come, first-served once mailing resumes (mail is already queued).
  4. Waiting to place your order is fine; we expect resolution soon, but mail is piling up worldwide, not only with our firm.
  5. We ship normally to the UK, AUS, Japan, and most others. The hold is on the USA side only.
Thanks for your patience.
Examples of Packages sent

 

What is this drug used for?

It is used to lower blood sugar in patients with high blood sugar (diabetes).

 

Pronunciation

(re PAG li nide & met FOR min)

 

Medication Safety Issues

Sound-alike/look-alike issues:

PrandiMet may be confused with Avandamet, Prandin

 

Storage/Stability

Do not store above 25?C (77?F). Protect from moisture.

 

Adverse Reactions

The following information reflects the frequency of adverse effects experienced by patients who received the repaglinide/metformin fixed-dose combination product. Also see individual agents.

>10%:

Central nervous system: Headache (22%)

Endocrine & metabolic: Hypoglycemia (33%)

Gastrointestinal: Diarrhea (19%), nausea (15%)

Respiratory: Upper respiratory tract infection (11%)